These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
487 related articles for article (PubMed ID: 19335542)
1. Individual patients who experienced both Guillain-Barré syndrome and CIDP. Kuitwaard K; van der Pol WL; Ruts L; van Doorn PA J Peripher Nerv Syst; 2009 Mar; 14(1):66-8. PubMed ID: 19335542 [No Abstract] [Full Text] [Related]
2. Immunoglobulin for concurrent Guillain-Barré and immune thrombocytopenic purpura. Zeidman LA; Fahey CD; Grinblatt DL; Harsanyi K Pediatr Neurol; 2006 Jan; 34(1):60-2. PubMed ID: 16376282 [TBL] [Abstract][Full Text] [Related]
3. Corticosteroids can help distinguish between Guillain-Barré syndrome and first attack of chronic inflammatory demyelinating neuropathy: an illustrative case report. Alexander KJ; Alshubaili AF; Santhamoorthy P; Sharafuddin KM Med Princ Pract; 2008; 17(5):422-4. PubMed ID: 18685286 [TBL] [Abstract][Full Text] [Related]
4. Acquired inflammatory demyelinating neuropathies. Ensrud ER; Krivickas LS Phys Med Rehabil Clin N Am; 2001 May; 12(2):321-34, ix. PubMed ID: 11345010 [TBL] [Abstract][Full Text] [Related]
5. Treatment of Guillain-Barré syndrome and CIDP. van Doorn PA J Peripher Nerv Syst; 2005 Jun; 10(2):113-27. PubMed ID: 15958124 [TBL] [Abstract][Full Text] [Related]
13. Chronic inflammatory demyelinating polyneuropathy presenting with features of GBS. Mori K; Hattori N; Sugiura M; Koike H; Misu K; Ichimura M; Hirayama M; Sobue G Neurology; 2002 Mar; 58(6):979-82. PubMed ID: 11914423 [TBL] [Abstract][Full Text] [Related]
14. Modulatory effects on axonal function after intravenous immunoglobulin therapy in chronic inflammatory demyelinating polyneuropathy. Lin CS; Krishnan AV; Park SB; Kiernan MC Arch Neurol; 2011 Jul; 68(7):862-9. PubMed ID: 21747028 [TBL] [Abstract][Full Text] [Related]
15. [Facial diplejia: a regional variant of Guillain-Barré syndrome]. Piñol Ripoll G; Larrodé Pellicer P; de la Puerta González-Miró I; Tejero Juste C; Iñiguez Martínez C; Santos Lasaosa S; Mostacero Miguel E An Med Interna; 2007 Jan; 24(1):24-6. PubMed ID: 17373865 [TBL] [Abstract][Full Text] [Related]
17. Functional recovery of untreated human immunodeficiency virus-associated Guillain-Barré syndrome: a case report. Schreiber AL; Norbury JW; De Sousa EA Ann Phys Rehabil Med; 2011 Nov; 54(8):519-24. PubMed ID: 22036304 [TBL] [Abstract][Full Text] [Related]
18. Aberrated levels of cerebrospinal fluid chemokines in Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. Press R; Pashenkov M; Jin JP; Link H J Clin Immunol; 2003 Jul; 23(4):259-67. PubMed ID: 12959218 [TBL] [Abstract][Full Text] [Related]
19. [Present status of high-dose intravenous immunoglobulin therapy and the future prospects ]. Kawasugi K Nihon Rinsho Meneki Gakkai Kaishi; 2003 Jun; 26(3):87-95. PubMed ID: 12868126 [No Abstract] [Full Text] [Related]